<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04531215</url>
  </required_header>
  <id_info>
    <org_study_id>6236</org_study_id>
    <nct_id>NCT04531215</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Retrolaminar Versus Erector Spinae Plane Block for Postoperative Analgesia</brief_title>
  <official_title>Ultrasound Guided Retrolaminar Versus Erector Spinae Plane Block for Postoperative Analgesia in Modified Radical Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thoracic epidural anesthesia (TEA) and paravertebral block (PVB) have been utilized to give&#xD;
      perioperative regional anesthesia in the trunk. TEA is technically troublesome in some cases,&#xD;
      and is associated with a danger of serious complications, such as epidural hematoma, nerve&#xD;
      injury, and hypotension. PVB has the benefit of perception of the needle position using&#xD;
      ultrasonography. However, PVB is also additionally connected with a danger of serious&#xD;
      complications, such as pneumothorax, hypotension, or nerve injury. Newer approaches to deal&#xD;
      with PVB have been the focal point of numerous techniques lately; these methodologies&#xD;
      incorporate retrolaminar block (RLB) and erector spinae plane block (ESPB)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Modified radical mastectomy is one of the commonly performed breast surgery. Postoperative&#xD;
      pain following mastectomy should be minimized, as in a number of women it may chronically&#xD;
      persist for months in the form of post-mastectomy pain syndrome.&#xD;
&#xD;
      Morphine administration for acute pain after mastectomy surgery has many side effects.&#xD;
      Regional block techniques as para-vertebral block and thoracic epidural anesthesia have&#xD;
      possible complications and technical difficulties.&#xD;
&#xD;
      The new alternative regional techniques such as erector spinae plane block and retrolaminar&#xD;
      block are clinical trials for providing a safe and easy with good hemodynamic and recovery&#xD;
      profile with adequate perioperative analgesia for a large section of patients undergoing&#xD;
      mastectomy operation in order to reduce opioids consumption and subsequently avoid&#xD;
      opioid-related adverse effects.&#xD;
&#xD;
      As percent of post-operative rescue analgesia is 16.7% and 60% for RLB group and ESPB group&#xD;
      respectively. So, sample size is 46 patients (23 patients in each group). Sample was&#xD;
      calculated using OPEN EPI program with confidence level 95% and power 80%.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total fentanyl dose.</measure>
    <time_frame>from induction to end of surgery</time_frame>
    <description>The anesthesiologist will administer intravenous fentanyl 0.5 μg/kg when the heart rate or blood pressure of the patients increased &gt;20% from basal measurements after exclusion of other causes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain intensity by Visual Analogue Scale</measure>
    <time_frame>at 30 minutes then at 2, 4, 8, 12, 18 and 24 hours post-operatively.</time_frame>
    <description>• Static and dynamic pain scores (VAS) at 30 minutes, 2, 4, 8, 12, 18 and 24 hours post-operatively.&#xD;
pain intensity will be evaluated by Visual Analogue Scale (VAS). VAS is a 10 cm horizontal line labeled &quot;no pain&quot; at one end and &quot;worst pain&quot; imaginable on the other end. The patient will be asked to mark on this line where the intensity of the patient lies.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of requirement of rescue dose of Fentanyl.</measure>
    <time_frame>up to 24hour postoperative</time_frame>
    <description>Time of requirement of rescue dose of Fentanyl.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amount of postoperative Fentanyl</measure>
    <time_frame>up to 24hour postoperative</time_frame>
    <description>Total amount of Fentanyl consumed during the first 24 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative nausea and vomiting</measure>
    <time_frame>up to 24hour postoperative</time_frame>
    <description>• Post-operative nausea and vomiting will be noticed, recorded using a categorical scoring system (0 = none, 1 = mild, 2 = moderate, 3 = severe) and treated, Ondansetron 4 mg IV will be administered in case of reported nausea and/or vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications including hypotension MAP &lt; 60, bradycardia HR &lt; 60b/m, nausea, vomiting and allergic reactions.</measure>
    <time_frame>up to 24hour postoperative</time_frame>
    <description>Complications including hypotension MAP &lt; 60, bradycardia HR &lt; 60b/m, nausea, vomiting and allergic reactions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall patient satisfaction</measure>
    <time_frame>up to 24hour postoperative</time_frame>
    <description>• Overall patient satisfaction at the end of the 24 hours post-operative using short assessment patient satisfaction scale (SAPS scale fully satisfied, neutral satisfied or unsatisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">46</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>ultrasound guided Retrolaminar Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound guided Retrolaminar Block (RLB) with 20 ml (0.5% Bupivacaine) plus 5 mic/ml Adrenaline (1:200,000) at the level of T4 of the surgical side.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ultrasound guided erector spinae</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound guided Erector Spinae Plane Block (ESPB) with 20 ml (0.5% Bupivacaine) plus 5 mic/ml Adrenaline (1:200,000) at the level of T4 of the surgical side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ultrasound guided Retrolaminar Block</intervention_name>
    <description>ultrasound guided Retrolaminar Block (RLB) with 20 ml (0.5% Bupivacaine) plus 5 mic/ml Adrenaline (1:200,000) at the level of T4 of the surgical side</description>
    <arm_group_label>ultrasound guided Retrolaminar Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ultrasound guided Erector Spinae Plane</intervention_name>
    <description>ultrasound guided Erector Spinae Plane Block (ESPB) with 20 ml (0.5% Bupivacaine) plus 5 mic/ml Adrenaline (1:200,000) at the level of T4 of the surgical side.</description>
    <arm_group_label>ultrasound guided erector spinae</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient acceptance.&#xD;
&#xD;
          -  21 - 64 years of age.&#xD;
&#xD;
          -  American Society of Anesthesiologist physical status class I,II.&#xD;
&#xD;
          -  Body Mass Index 25-35 kg/m2.&#xD;
&#xD;
          -  Female patient undergoing elective unilateral modified radical mastectomy under&#xD;
             general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Coagulation disorders or anticoagulant therapy.&#xD;
&#xD;
          -  Known allergy to study drugs (Bupivacaine, Fentanyl)&#xD;
&#xD;
          -  Infection at the injection site.&#xD;
&#xD;
          -  Patients having chronic pain or on pain treatment.&#xD;
&#xD;
          -  Advanced renal, respiratory, hepatic or cardiovascular disorders.&#xD;
&#xD;
          -  Uncooperative patients.&#xD;
&#xD;
          -  Duration of surgery &gt; 3hours.&#xD;
&#xD;
          -  Pregnant or lactating females.&#xD;
&#xD;
          -  Metastasis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alshaimaa Kamel, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alshaimaa Kamel, M.D</last_name>
    <phone>01005593169</phone>
    <phone_ext>002</phone_ext>
    <email>AlshaimaaKamel80@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mai Alahmady, MBBCH</last_name>
    <phone>01000314543</phone>
    <phone_ext>002</phone_ext>
    <email>alahmadymai@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zagazig University, Faculty of medicine</name>
      <address>
        <city>Zagazig</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alshaimaa Kamel, M.D</last_name>
      <phone>01005593169</phone>
      <phone_ext>002</phone_ext>
      <email>AlshaimaaKamel80@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Alshaimaa Kamel, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Alshaimaa Abdel Fattah Kamel</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

